![1]()
News
Discontinuing Inhaled Corticosteroids in COPD Reduces Risk of Pneumonia
March 25, 2016
Clinical question: Is discontinuation of inhaled corticosteroids (ICSs) in patients with COPD associated with a decreased risk of pneumonia? Background: ICSs are used in up to 85% of patients treated for COPD but may be associated with adverse systemic side effects including pneumonia.
News
Corticosteroids Improve Outcomes in Community- Acquired Pneumonia
December 1, 2015
Clinical question: Are adjunctive corticosteroids beneficial for patients hospitalized with community-acquired pneumonia (CAP)? Background: Numerous studies have tried to determine whether or not adjunctive corticosteroids for CAP treatment in hospitalized patients improve outcomes.
News
Steroids Beneficial as Adjunctive Treatment for Community-Acquired Pneumonia
November 30, 2015
Clinical question: Should steroids be used as adjunctive therapy for patients with community-acquired pneumonia? Bottom line: Moderate-quality to high-quality evidence suggests that steroids, when added to antibiotics and usual care, can improve outcomes in the treatment of community-acquired pne
News
Oral Steroids Not Inferior to Intravenous Steroids in Multiple Sclerosis Relapses
November 4, 2015
Clinical question: Is there any difference between oral and intravenous methylprednisolone for multiple sclerosis relapses? Background: When relapses of multiple sclerosis occur, studies have shown that intravenous steroids are the treatment of choice.
News
Corticosteroids Show Benefit in Community-Acquired Pneumonia
August 25, 2015
Clinical question: Does corticosteroid treatment shorten systemic illness in patients admitted to the hospital for community-acquired pneumonia (CAP)? Background: Pneumonia is the third-leading cause of death worldwide.
News
Corticosteroids Show Benefit in Community-Acquired Pneumonia
July 29, 2015
Joshua LaBrin, MD, SFHM, Kencee Graves, MD, Karli Edholm, MD, Devin Horton, MD, and Katie Lappe, MD; Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City
News
Steroids May Benefit Patients With Severe CAP and High CRP Levels
April 13, 2015
Clinical question: Do steroids improve outcomes in patients with severe community-acquired pneumonia and a high inflammatory response? Bottom line In patients with severe community-acquired pneumonia (CAP) who have elevated levels of C-reactive protein (CRP), a short course of methylprednisolone
Audio
LISTEN NOW: Jeffrey Greenwald, MD provides tips on treating endocrine disorders
April 4, 2015
Jeffrey Greenwald, MD, a hospitalist at Massacusetts General Hospital with 15 years of experience in hospital medicine, discusses his view of the spectrum of endocrine disorders and how hospitalists should approach the question of when to call in an endocrine specialist. [audio mp3="http://www.th
![1]()
News
Nine Things Hospitalists Need to Know about Treating Patients with Endocrine Disorders
April 3, 2015
Diabetes is as prevalent in hospitals today as lab coats and heart monitors. More than 8% of the population—almost 26 million people—and nearly 27% (11 million) of Americans 65 or older have diabetes, according to American Diabetes Association (ADA) statistics.
News
Inhaled Corticosteroids Decrease Inflammation in Moderate to Severe COPD
October 29, 2014
Clinical question: Does long-term inhaled corticosteroid therapy, with and without long-acting beta-agonists, decrease airway inflammation and improve lung function in patients with moderate to severe chronic obstructive pulmonary disease (COPD)? Background: Guideline-recommended treatment of COP
